Clinical trial · Interventional
Screening to Predict Weight Loss in Patients With Cancer
Predicting Weight Loss in People With Cancer: Development of a Screening Tool
NCT00710632CI-TRIAL-00012093unknownN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
RATIONALE: Screening tests may identify people with cancer who are at high risk of losing weight and help doctors plan better treatment. PURPOSE: This clinical trial is studying how well a new screening tool works in predicting weight loss in patients with cancer.
Conditions
Conditions (5)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cachexia | — | UNRESOLVED | — |
| Gastrointestinal Cancer | Malignant Digestive System Neoplasm | ALIAS | 0.90 |
| Hematopoietic/Lymphoid Cancer | — | UNRESOLVED | — |
| Lung Cancer | Malignant Lung Neoplasm | CURATED_EXACT | 0.92 |
| Unspecified Adult Solid Tumor, Protocol Specific | Adult Solid Neoplasm | ALIAS | 0.85 |
Interventions
Interventions (4)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| laboratory biomarker analysis | Other | — | UNRESOLVED |
| management of therapy complications | Procedure | — | UNRESOLVED |
| physiologic testing | Other | — | UNRESOLVED |
| questionnaire administration | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (5)
- measure
- Percentage weight loss by measuring height and weight at baseline and at 3 months
- measure
- Malnutrition Universal Screening Tool Score at initial screening
- measure
- Response to the Appetite and Symptom Questionnaire at baseline
- measure
- Level of blood C-reactive protein at baseline
- measure
- Clinical condition, defined as diagnosis and stage of disease, treatment, and performance status at baseline
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
DISEASE CHARACTERISTICS:
* Meets 1 of the following criteria, depending on part of study:
* Part 1:
* Receiving radiotherapy for cancer at Nottingham City Hospital
* Likely to be clinically stable over the duration of one week (i.e., not at high risk of disease or treatment-related appetite and weight loss)
* Stable weight and appetite
* Part 2:
* Outpatient at Nottingham City Hospital with a confirmed diagnosis of primary lung or gastrointestinal cancer
* Lost no more than 10% of pre-illness stable body weight
* Lost no more than 5% of pre-illness stable body weight if body mass index (BMI) was less than 20 kg/m\^2
* BMI ≥ 18.5 kg/m\^2
PATIENT CHARACTERISTICS:
* No condition impairing the ability to swallow
* Not receiving enteral tube feeding or parenteral nutrition (part 2)
* Able to be weighed (part 2)
PRIOR CONCURRENT THERAPY:
* See Disease Characteristics
* No concurrent radiotherapy to the head, neck or upper gastrointestinal tract areaReferences
Publications (0)
Data not yet available
No reference posted for this study.